Disease Areas
Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests
Startup Spesana's digital platform will integrate EMR, lab information, and MDx data to automate clinical workflows, tumor boards, and clinical trial management.
Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay
The assay, which runs on the company's Idylla platform, distinguishes sepsis from noninfectious systemic inflammation.
BioMark Diagnostics, AstraZeneca, Pfizer, Others Partner in Lung Cancer Screening Project
The collaborators aim to develop tools that combine AI with radiomic, genetic, and metabolomic biomarkers for lung cancer screening.
Qiagen, DiaSorin Obtain FDA Approval for Latent TB Test on Benchtop Platform
The approval broadens accessibility in the US to a highly automated workflow for latent TB testing using a blood-based assay and benchtop platform.
HER2 Treatments See New Milestones in Colorectal Cancer, With Liquid Biopsy Identifying Responders
Premium
New data from a Japanese Phase II study have solidified a path forward for pertuzumab plus trastuzumab in HER2-positive colorectal cancer patients.
Nov 24, 2021
NGeneBio Gets CE-IVD Mark for HLA Typing Assay
Nov 22, 2021
Cancer Dx Firms ACT Genomics, Sanomics Merge
Nov 17, 2021
Nov 16, 2021
Geneoscopy Closes $105M Series B Financing Round
Nov 15, 2021
Nov 10, 2021
Cue Health Revenues up Massively in Q3
Nov 10, 2021